Obesity, Appetite Control & Diabetes
Obesity, Appetite Control & Diabetes
Satiety, appetite, and craving are CNS drives, whereas metabolism and energy utilization are peripheral endocrine actions.
Stephen M. Stahl, M.D., Ph.D. read more
Research Areas
Products Related to Obesity, Appetite Control & Diabetes(354)
- GC92116Semaglutide Main Chain (9-37)CAS: 1169630-82-3Purity: >98.00%
Semaglutide main chain (9-37) is a peptide starting material in the synthesis of semaglutide.
- GC92118Taspoglutide (acetate)CAS: 1022150-16-8Purity: >98.00%
Taspoglutide is an agonist of the glucagon-like peptide 1 receptor (GLP-1R; Ki = 1.1 nM for the human receptor).
- GC92119GLP-1 (7-36) acid (human, mouse, rat, porcine, bovine)Purity: >98.00%
Glucagon-like peptide 1 (GLP-1) (7-36) acid is a derivative of the hormone and GLP-1 receptor (GLP-1R) agonist GLP-1 (7-36) amide.
- GC92122KBP-066 (trifluoroacetate salt)Purity: >95.00%
KBP-066 is a dual amylin and calcitonin (CT) receptor agonist.
- GC92125Liraglutide (acetate)CAS: 1997361-86-0Purity: >95.00%
Liraglutide is a potent agonist of the glucagon-like peptide 1 (GLP-1) receptor and a synthetic derivative of GLP-1 (7-37) that contains a palmitic acid group.
- GC92128Dapiglutide (sodium salt)Purity: >98.00%
Dapiglutide is a dual glucagon-like peptide 1 receptor (GLP-1R) and GLP-2R agonist.
- GC92131NN1177 (trifluoroacetate salt)Purity: >98.00%
NN1177 is a dual peptide agonist of the glucagon receptor (GCGR) and glucagon-like peptide 1 receptor (GLP-1R).
- GC92132SAR441255 (sodium salt)Purity: >95.00%
SAR441255 is a peptide triple agonist of the glucagon-like peptide 1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GCGR).
- GC92133Glucose-dependent Insulinotropic Polypeptide (1-42) (porcine) (trifluoroacetate salt)Purity: >98.00%
Glucose-dependent Insulinotropic Polypeptide (GIP) (1-42) is an endogenous 42-amino acid peptide incretin hormone that induces insulin secretion.
- GC92134Glucose-dependent Insulinotropic Polypeptide (human) (trifluoroacetate salt)Purity: >95.00%
Glucose-dependent Insulinotropic Polypeptide (GIP) (human) is an endogenous 42-amino acid peptide incretin hormone that induces insulin secretion in response to glucose.
- GP10060a-MSH, amideCAS: 581-05-5Purity: >98.00%
a-MSH (α-Melanocyte-Stimulating Hormone), amide engages the melanocortin-1 receptor and activates cyclic AMP (cAMP) signaling via a G-protein transporter, can synthesize melanin.
- GP10126Diazepam-Binding Inhibitor Fragment, humanCAS: 104360-70-5Purity: >98%
Diazepam-Binding Inhibitor (DBI) Fragment is encoded by the DBI gene in human.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC92116 | Semaglutide Main Chain (9-37) | 1169630-82-3 | >98.00% | |
Semaglutide main chain (9-37) is a peptide starting material in the synthesis of semaglutide. | ||||
| GC92118 | Taspoglutide (acetate) | 1022150-16-8 | >98.00% | |
Taspoglutide is an agonist of the glucagon-like peptide 1 receptor (GLP-1R; Ki = 1.1 nM for the human receptor). | ||||
| GC92119 | GLP-1 (7-36) acid (human, mouse, rat, porcine, bovine) | - | >98.00% | |
Glucagon-like peptide 1 (GLP-1) (7-36) acid is a derivative of the hormone and GLP-1 receptor (GLP-1R) agonist GLP-1 (7-36) amide. | ||||
| GC92122 | KBP-066 (trifluoroacetate salt) | - | >95.00% | |
KBP-066 is a dual amylin and calcitonin (CT) receptor agonist. | ||||
| GC92125 | Liraglutide (acetate) | 1997361-86-0 | >95.00% | |
Liraglutide is a potent agonist of the glucagon-like peptide 1 (GLP-1) receptor and a synthetic derivative of GLP-1 (7-37) that contains a palmitic acid group. | ||||
| GC92128 | Dapiglutide (sodium salt) | - | >98.00% | |
Dapiglutide is a dual glucagon-like peptide 1 receptor (GLP-1R) and GLP-2R agonist. | ||||
| GC92131 | NN1177 (trifluoroacetate salt) | - | >98.00% | |
NN1177 is a dual peptide agonist of the glucagon receptor (GCGR) and glucagon-like peptide 1 receptor (GLP-1R). | ||||
| GC92132 | SAR441255 (sodium salt) | - | >95.00% | |
SAR441255 is a peptide triple agonist of the glucagon-like peptide 1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GCGR). | ||||
| GC92133 | Glucose-dependent Insulinotropic Polypeptide (1-42) (porcine) (trifluoroacetate salt) | - | >98.00% | |
Glucose-dependent Insulinotropic Polypeptide (GIP) (1-42) is an endogenous 42-amino acid peptide incretin hormone that induces insulin secretion. | ||||
| GC92134 | Glucose-dependent Insulinotropic Polypeptide (human) (trifluoroacetate salt) | - | >95.00% | |
Glucose-dependent Insulinotropic Polypeptide (GIP) (human) is an endogenous 42-amino acid peptide incretin hormone that induces insulin secretion in response to glucose. | ||||
| GP10031 | Leptin (116-130) amide (mouse) | 258276-95-8 | >99.00% | |
| GP10060 | a-MSH, amide | 581-05-5 | >98.00% | |
a-MSH (α-Melanocyte-Stimulating Hormone), amide engages the melanocortin-1 receptor and activates cyclic AMP (cAMP) signaling via a G-protein transporter, can synthesize melanin. | ||||
| GP10065 | Endomorphin-1 | 189388-22-5 | >98% | |
| GP10066 | Melanocyte stimulating hormone release inhibiting factor | 2002-44-0 | >98% | |
| GP10076 | Agouti-related Protein (AGRP) (25-82), human | - | >98% | |
| GP10122 | Glucagon (19-29), human | 64790-15-4 | >98.50% | |
| GP10126 | Diazepam-Binding Inhibitor Fragment, human | 104360-70-5 | >98% | |
Diazepam-Binding Inhibitor (DBI) Fragment is encoded by the DBI gene in human. | ||||
| GP10131 | Peptide YY(3-36), PYY, human | 123583-37-9 | >98% | |